IPSC – century therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know [Yahoo! Finance]
Century Therapeutics (NASDAQ:IPSC) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes [Yahoo! Finance]
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes
Century Therapeutics (NASDAQ:IPSC) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Form SCHEDULE 13G Century Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Form SCHEDULE 13G Century Therapeutics, Filed by: Venrock Healthcare Capital Partners III, L.P.
Form SCHEDULE 13G Century Therapeutics, Filed by: Commodore Capital LP
Form SCHEDULE 13G Century Therapeutics, Filed by: TCG Crossover GP II, LLC
Form SCHEDULE 13G Century Therapeutics, Filed by: Deep Track Capital, LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.